本頁面由Tiger Trade Technology Pte. Ltd.提供服務

福泰製藥

552.85
+5.260.96%
盤後554.781.93+0.35%19:56 EDT
成交量:77.50萬
成交額:4.28億
市值:1,402.68億
市盈率:32.18
高:555.69
開:545.53
低:543.75
收:547.59
52周最高:555.69
52周最低:374.17
股本:2.54億
流通股本:2.54億
量比:0.66
換手率:0.31%
股息:- -
股息率:- -
每股收益(TTM):17.18
每股收益(LYR):15.32
淨資產收益率:23.54%
總資產收益率:11.93%
市淨率:6.93
市盈率(LYR):36.09

資料載入中...

2025/02/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/13

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/20

重要事件披露

Form 8-K - Current report
2024/11/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/04

重要事件披露

Form 8-K - Current report
2024/10/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities